Biomerieux SA - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Biomerieux SA. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Biomerieux SA. The Group's principal activity is to provide clinical diagnosis. The Group offers 'in vitro' diagnosis which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. The Group contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. The Group performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. The industrial applications include the analysis of the industrial sample like food, pharmaceutical and cosmetic products. The environment sample of water, air and surface determines the microbiological quality. The Group operates in Europe, North America, Asia-Pacific and Latin America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report